143 related articles for article (PubMed ID: 15790508)
1. Engineering of human complement component C3 for catalytic inhibition of complement.
Kölln J; Bredehorst R; Spillner E
Immunol Lett; 2005 Apr; 98(1):49-56. PubMed ID: 15790508
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
3. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
4. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
5. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
6. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
8. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
9. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
Sandoval A; Ai R; Ostresh JM; Ogata RT
J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
[TBL] [Abstract][Full Text] [Related]
10. Primary structure of cobra complement component C3.
Fritzinger DC; Petrella EC; Connelly MB; Bredehorst R; Vogel CW
J Immunol; 1992 Dec; 149(11):3554-62. PubMed ID: 1431125
[TBL] [Abstract][Full Text] [Related]
11. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
Rehana S; Manjunatha Kini R
Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
13. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
[TBL] [Abstract][Full Text] [Related]
14. Complement inactivation by recombinant human C3 derivatives.
Kölln J; Spillner E; Andrä J; Klensang K; Bredehorst R
J Immunol; 2004 Nov; 173(9):5540-5. PubMed ID: 15494503
[TBL] [Abstract][Full Text] [Related]
15. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
16. Spermatogenic cells distal to the blood-testis barrier in rats lack C3 convertase regulators and may be at risk of complement-mediated injury.
Mizuno M; Harris CL; Morgan BP
J Reprod Immunol; 2006 Feb; 69(1):23-34. PubMed ID: 16380167
[TBL] [Abstract][Full Text] [Related]
17. Active sites in complement component C3 mapped by mutations at indels.
Ogata RT; Ai R; Low PJ
J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
[TBL] [Abstract][Full Text] [Related]
20. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]